There are an overwhelming number of reports indicating the beneficial effects of fish oil supplements in human and animal nutrition. The purpose of this study, second in a series, was to evaluate the effects, particularly those that may be harmful, of high-dose, long-term consumption of fish oil concentrates (FOC) using male and female rats. One hun dred and twenty male and 120 female rats were gavaged daily with oils and oil mixtures in a volume equal to 0.5% body weight (5mL/kg/d) for 13 weeks. The administered oils were corn oil, pure menhaden oil (MO), pure MaxEPA_??_ fish oil or different mixtures of corn oil with MO. The stability and the homogeneity of the dosing solutions were tested under study conditions. The animals received isocaloric and isonitrogenous diets throughout. Food and pure water were supplied ad libitum. At the end of the in-life phase of the study, the animals were anaesthetized with CO2 and humanely killed by exsanguination. Blood and other tis sues were prepared for various clinical, histopathological and laboratory tests. Some benefi cial effects of FOC, such as reduction in total serum cholesterol, in rats were confirmed. However, we also observed a significant reduction in absolute amount of serum HDL and a significant increase in relative liver and spleen weights in both sexes with the high dose of FOC. High doses of FOC (5mL/kg/d) reduced serum iron and vitamin E concentrations. A reduction in osmotic fragility of RBC as well as an increase in RBC deformity were also ob served in rats treated with high doses of FOC. These rats showed a significant overall in crease in WBC count. We conclude that in rats, subchronic consumption of high levels of FOC can be beneficial but may also be harmful because of induction of clinical abnormalities including increased red cell deformity, increased relative liver and spleen weights, and re duced serum HDL, iron and vitamin E concentrations.
Summary There are an overwhelming number of reports indicating the beneficial effects of fish oil supplements in human and animal nutrition. The purpose of this study, second in a series, was to evaluate the effects, particularly those that may be harmful, of high-dose, long-term consumption of fish oil concentrates (FOC) using male and female rats. One hun dred and twenty male and 120 female rats were gavaged daily with oils and oil mixtures in a volume equal to 0.5% body weight (5mL/kg/d) for 13 weeks. The administered oils were corn oil, pure menhaden oil (MO), pure MaxEPA_??_ fish oil or different mixtures of corn oil with MO. The stability and the homogeneity of the dosing solutions were tested under study conditions. The animals received isocaloric and isonitrogenous diets throughout. Food and pure water were supplied ad libitum. At the end of the in-life phase of the study, the animals were anaesthetized with CO2 and humanely killed by exsanguination. Blood and other tis sues were prepared for various clinical, histopathological and laboratory tests. Some benefi cial effects of FOC, such as reduction in total serum cholesterol, in rats were confirmed. However, we also observed a significant reduction in absolute amount of serum HDL and a significant increase in relative liver and spleen weights in both sexes with the high dose of FOC. High doses of FOC (5mL/kg/d) reduced serum iron and vitamin E concentrations. A reduction in osmotic fragility of RBC as well as an increase in RBC deformity were also ob served in rats treated with high doses of FOC. These rats showed a significant overall in crease in WBC count. We conclude that in rats, subchronic consumption of high levels of FOC can be beneficial but may also be harmful because of induction of clinical abnormalities including increased red cell deformity, increased relative liver and spleen weights, and re duced serum HDL, iron and vitamin E concentrations. Key Words subchronic toxicity, fish oil concentrates, n-3 fatty acids Fish oil concentrates (FOC) which contain omega-3 fatty acids are becoming increasingly popular due to their purported beneficial effects in prevention and/or treatment of many diseases including cardiovascular disease and cancer (1) (2) (3) (4) (5) . Some scientists suggest pro phylactic use of n-3 fatty acids through a broad food en richment (6). Reports concerning the beneficial effects of FOC supplements in health and diseases are conflict ing (7-10). Some reports indicate that there may be harmful effects associated with either prolonged inges tion or acute ingestion of large quantities of the omega 3 fatty acids (11). These include development of aneurisms and increased risk of stroke (12) and infec tions (13), modulation of the immune system (14), en hancement of ethanol (15) or acetaminophen-induced hepatotoxicity (16), lipidosis (17), enhancement of fatty streak (18) and plaque formation (19) in the aorta, and detrimental effects on glucose tolerance in type II dia betics (20) . Other harmful effects related to the con sumption of FOC were reported in both animals (21) and humans (22) . A study was conducted with MaxEPA_??_, a commercially available FOC, to obtain an indication of any clinical, biochemical, or pathological problems that might result from a 65-day (5d/wk for 13 weeks) high-level administration of this FOC (23). This follow-up 90-day study (7d/wk for 13 weeks) pre sented herein was performed using MO, a relatively crude fish oil that was well characterized and provided by the National Marine Fisheries Service (NMFS) for use in clinical or non-clinical studies. To facilitate compar isons with our previous study, twenty male and twenty female rats were also treated with MaxEPA_??_ at the high dose level of 5mL/kg/d for 13 weeks.
MATERIALS AND METHODS
The oils, animal care and treatments. The National Marine Fisheries Service (NMFS), Southeast Fisheries Center, Charleston Laboratory, Charleston, SC, USA, provided MO in polyethylene plastic containers. This crude fish oil contained a total of 29.9% n-3 fatty acids (FA) including 9.2% docosahexaenoic acid (DHA) and 12.9% eicosapentaenoic acid (EPA). Contaminants in the oil, determined by the NMFS, were polychlorinated biphenyl (PCB) <0.05ppm
and dichlorodiphenyl trichloroethane (DDT) <0.004ppm. The oil also con tained 0.02% TBHQ, an antioxidant, and 2.2mg/mL of vitamin E. termined at the beginning and at the end of feeding pe riod (Centech Laboratories St. Louis, MO, USA) to pro vide stability data for the test and control articles and the data are summarized in Table 2 . Euthanasia, necropsy and clinical tests. At the con clusion of the in-life phase of the study, animals were anaesthetized with excess CO2, weighed, humanely killed by exsanguination via the posterior vena cava, and necropsied. During each day of necropsy, four rats from each treatment group (total of 24 rats from each sex) were randomly selected for euthanasia. Blood was drawn using a 20mL plastic syringe and a stainless steel needle, 21g and 1.5 inch long. Osmotic fragility of the red blood cells (OFRBC) was determined immedi ately according to the method of Dacie and Lewis (28) . Prothrombin time (PT) and activated partial thrombo plastin time (aPTT), two of the many coagulation in dices, were determined by using Coag-A-Mate Model X2 (Organon Teknika, Oklahoma City, OK, USA), immedi ately after necropsy. Whole blood, serum and plasma specimens were also prepared for hematological and clinical chemistry tests by MetPath company (MetPath Inc., Rockville, MD, USA). These included complete blood count (CBC) with differentials, platelet counts, hemoglobin and hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), MCH concentration (MCHC), red blood cell distribution width (RDW), mean platelet volume (MPV), % neutrophils, lymphocytes, monocytes, eosinophil and platelets, glu 
RESULTS
Average weekly food consumption and weekly weight gain are summarized in Table 3 . Fish oil consumption showed little or no effect on these parameters except at the highest dose level where food consumption in creased significantly. In general, the average weekly weight gain was not affected by treatment. High doses of fish oils caused a significant increase in relative liver and spleen weights (Table 4) , but did not affect the rela tive weights of other tissues. Serum triglyceride (TG) level was not affected by fish oil, while the total serum cholesterol (TCh) and absolute amount of serum HDL were reduced significantly. These effects were more pronounced in female than in male rats (Table 5 ). However, both total cholesterol and the HDL data in the three female groups (control, treat ments I & II) had very high standard deviations. Nevertheless, the dose effect toward lower serum TCh and HDL determined by a two-way ANOVA, was highly significant (p<0.0002).
Two of the factors involved in the coagulation process, plasma PT and aPPT, were not affected by fish oil treatments (Table 6) . A 10% increase in the white blood cell count was observed in both sexes. This in crease in leukocyte count was statistically significant when the male and female data were pooled and a two way ANOVA was applied (p<0.0056). The mean platelet volume in the two highest dose groups was sig nificantly reduced while the RDw was significantly ele vated in both sexes in the highest dose levels. There was also a trend in lessening of OFRBC, but this was statisti cally significant only when two-way ANOVA was ap plied (Table 6 ). Clinical chemistry data are presented in Table 7 . Serum concentration of BUN increased in fe male rats receiving the highest dose of MO, while the concentration of serum creatinine significantly declined in the female rats. In male rats, some serum enzyme ac tivities (SCOT and LDH) were affected by the high doses Table 3 .
Average weekly food consumption and weight gain. of fish oil intake. While serum chloride concentration was slightly elevated in the high-dose male rats, serum phosphorus level was slightly reduced in the highest dose of MO treated female rats (Table 8) . The dose effect, as determined by two-way ANOVA, was statistically sig nificant. The data on serum levels of iron and vitamin E show a significant decrease primarily in female rats (Table 8) . To examine the overall dose response of the variables mentioned in this study, a linear correlation between dose levels and the variables was performed, and the data are summarized in Table 9 . The following parameters were similarly affected in both sexes: rela tive liver weight, RDW, MPV, OFRBC, serum phospho rous, vitamin E and HDL. The histochemical analysis of the liver peroxisomas (CAT enzyme) showed no sign of peroxisomal proliferation (data not shown).
DISCUSSION
Our study of FOC was designed with dosing solutions with parameters similar to those used by other investi gators (31) who based their studies on the n-3/n-6 ra tios (Table 1) . These values were similar to the fish oil values in the dosing solutions, and we used the actual amount of fish oil for the statistical analysis rather than the ratios of the fish oil components. During the course of the study, the EPA and DHA concentrations of the dosing solutions as well as the FA profile of the oils were monitored along with their peroxide values (PV) to en sure the use of homogeneous and stable doses through out.
It is known that rats treated with fish oil tend to spill food (32) . In our study this was observed in the high dose groups (Table 3) . Although food consumption was significantly higher in the high-dose groups, little or no difference was observed in average weekly weight gain, the female rats on high-doses of MO excepted. These an imals gained about 2g/wk more than the control group. Although this small weight gain was statistically significant (p<0.0057), it seems unlikely that this fac tor affected the outcome of this study. In fact, the two way ANOVA showed no significant dose effect on weight gain despite a highly significant effect on appar ent food consumption (Table 3, p<0.0005). The data presented in Tables 4 to 9 , cannot be explained by fac tors other than our treatment.
Similar to the results of our earlier study with MaxEPA_??_, the relative liver and spleen weights were sig nificantly elevated with the highest doses of FOC ( Table Table 6 . Some hematological data. 
4).
In the human population, hepatosplenomegaly has been reported as a result of nutritional zinc deficiency (33). Although we did not assess the mineral status of animals, it is possible that a mild zinc deficiency linked to decreased mineral absorption was caused by high fish oil intake. Enlargement of the liver and spleen in our study did not appear to be as severe as that ob served in human zinc deficiency, In any event, the pathological examinations of these organs failed to pro vide adequate morphological and/or other information to explain the increase in relative organ weights. An ac curate test of peroxisomal proliferation would have been useful in explaining the increase in relative organ weight (34) . However, in a recent report on mice treated with fish oil for 30days, a 40% increase in spleen size was observed when compared to the soy bean oil control group (35) . This confirms our finding on enlagement of spleen size in ratss as a result of treat ment with Menhaden oil (Table 4) . A significant in crease in the concentration of RBC phosphatidylcholine hydroperoxide as well as phosphatidyl-ethanolamine hydroperoxide was also found in the mice treated with fish oil (35) . The histopathological data on most of the tissues we examined were unremarkable. In the present study, a 23 to 26% reduction in serum TG was observed in the high-dose female groups. Statistically, this reduction was not significant (Table 5) . A study of 19 healthy human volunteers who received 6g/d of MaxEPA fish oil for 21days also showed no sig nificant change in serum TG (36) . In contrast, other in vestigators have reported a significant reduction in serum TG in miniature pigs treated with fish oil (37) , in hypertriglyceridemic subjects receiving PUFA (38) and in female rats treated with MaxEPA in an amount equal to 0.5% body weight, 5 days a week for 13 wk (23). Moreover, a recent review on the subject (39) revealed a dose response decrease in blood TG levels in hyper triglyceridemic patients receiving high doses of fish oil supplements which persisted as long as supplementa tion continued. Although the values for female rats were within the reported normal range (40) , the nega tive correlations between dose levels and serum TG were significant in this study (Table 9 ) and in our previ ous study (23) which confirms the TG-lowering effect of fish oil in female rats. The total cholesterol values were within the reported normal range (40) but were signifi cantly reduced (22%) by treatment with the high doses of fish oil (Table 5 ). These data support the findings by others who found significant reduction in serum cho lesterol caused by fish oil ingestion (41), possibly through increased cholesterol secretion into bile (42) . However, this was associated with a significant reduc tion (22%) in absolute amount of serum HDL level as well (Table 5 ), The two-way ANOVA indicates highly significant dose effect in reducing serum cholesterol and HDL (p<0.0002). In fact, the HDL-lowering effect of dietary fish oil or n-3 fatty acids has been reported in rats (43) (Table  6 ). It may be specu lated that this was a compensatory response to a subtle hemolysis, as evidenced by enlarged spleen (Table 4) , and/or to a diminished intestinal iron absorption caused by high level ingestion of PUFA. In fact, this may be supported by another finding, e.g. a decrease in serum iron, especially in the high-dose female rats (Tables 8 and 9 ). Increase in the RDW rate has been re ported in infant anemia (57) and in a-thalassemia (58). However, we found no sign of anemia in the FOC treated animals, and we cannot explain with certainity the underlying mechanism and biological conse quences of this observation on RDW. In our study (Table 7) , blood urea nitrogen (BUN) was elevated by 8% in male (statistically not significant) and 18% in female rats (p<0.0028). Since in rats, BUN level does not appear to vary with sex or age (59), we cannot explain the sex difference in BUN response to high doses of FOC. In humans with acute renal failure, the BUN level can be used as an indicator of protein ca tabolism (60) . Although the BUN values in our study were within the reported normal range (46), the pathology data did nottot show kidney and/or renal tubu lar damage, which may have accounted for the high level of BUN in female rats (p<0.0222). However, as in dicated in Table 4 , the high-dose treated female rats ex hibited an 8.5% increase in relative liver weight. This may partially explain the increase in their BUN level.
Creatinine is a product of muscle metabolism, and its serum levels are directly related to muscular condition ing. According to Everett and Harrison (61) , factors that increase serum Creatinine levels will also elevate the BUN levels. The data presented in Table 7 contradict this conclusion by Everett and Harrison because the BUN level slightly increased in high-dose groups, while the serum creatinine levels significantly decreased (p<0.0390). The animals on high doses of FOC were more sedentary, thus rendering lower serum creatinine levels. It is important to note that the BUN/Creatinine ratios were significantly increased in the high dose groups of female and that the overall dose effect on the ratio of these variables was highly significant (Table 7 , p<0.0093). In any event, all the BUN and creatinine values presented in Table 7 were within the normal range reported in the literature (54), and these changes may be considered biologically insignificant. There was a significant dose effect on the SCOT values (p<0.0117). Also the SCOT/SGPT ratios were reduced at all dose levels. However, the SCOT values were be yond the average values reported in the literature (54) making it difficult to interpret the data. Likewise, the data on serum total LDH are directionally inconsistent.
The blood electrolyte data show that serum chloride values increased significantly (MO, p<0.0281 and MaxEPA_??_, p<0.0035, Table 8 ) with high doses of fish oil in male rats. However, these values were below those reported in the normal range (54). In our study, the overall dose effect in the pooled male and female data was highly significant (p<0.0028). Wickwire et al. (62) reported accelerated renal disease in rats fed a 9% MO diet; Tateno et al. (63) reported a BSA-induced immune complex nephritis in mice fed a casein-based diet con taming 10% fish oil concentrate. Therefore, in conjunc tion with the observed increase in BUN/Creatinine ratio (Table 7) , further investigation is warranted on the ef fects of long-term, high-dose intake of fish oil concen trates on renal function. As shown in Table 8 , a modest reduction in serum phosphorous level was observed in the high-dose female rats (p<0.0109). The pooled male and female data also showed a significant dose effect (p<0.0216). However, our values seem to be within the upper limits of the reported normal range (54), and it probably should be considered a statistical aberration without biological significance.
Our data showed that FOC lowered serum iron level in female rats by 34% (Table 8) . We are unable to ex plain the apparent suceptibility of serum iron in female rats to FOC, but this finding confirmed our previous study (23), However, in the present study, the serum iron values in both sexes were above the reported nor mal values (54). In humans, a daily intake of 20 mL of FOC in both sexes for ten weeks resulted in a significant reduction in serum and erythrocyte selenium concen trations (64) . Rats receiving sardine oil for 4 weeks, showed a significant reduction in dietary iron absorp tion and retention (65) . Another potentially harmful ef fect of high doses of FOC was a 48% reduction in serum vitamin E level in female rats and a 17% reduction in male rats both of which were statistically significant ( Table 8) . The overall dose effect on both parameters, serum iron and vitamin E, were highly significant (p<0.0002). These findings are in agreement with the report of a significant decrease in both serum and liver concentration of vitamin E when rats were fed diets high in FOC (66) . Likewise, our earlier studies showed that gavaging MaxEPA_??_ to rats (23) or feeding MO to miniature swine (67) resulted in a significant reduction in vitamin E levels in serum and in liver, respectively.
High levels of dietary polyunsaturated fatty acids (PUFA) appears to reduce the intestinal absorption of iron (Table 8) while increasing the body's demand for vitamin E (68, 69) . It must be noted that all the oils used in this study were adequately and equally fortified with both TBHO and vitamin E. It is possible that the vi tamin E intake was either inadequate and/or not ab sorbed in amounts sufficient to compensate for the ad ditional burden imposed on the antioxidant system of the animals by the high intake of PUFA, leading to re duced body store of vitamin E.
The dose response of some variables are presented in Table 9 . Negative control groups for both sexes to elimi nate possible oil effect were not included in the study. Although some of the p values were highly significant, the overall correlation coefficients were small and the effects were apparent mostly at the highest dose levels. Nevertheless, some of these changes may be biologically significant. The positive correlations between dose lev els and relative organ size and RDW may be considered unwanted side effects of consumption of high quantities of fish oil concentrates. Likewise, with the exceptions of OFRBC and serum phosphorous levels, all the negative correlations between dose levels and other parameters were highly significant. That included serum iron in fe male rats (r=-0.444, p<0.0002) and serum vitamin E and absolute amount of HDL concentrations in both sexes.
While long-term administration of high doses of fish oil had little or no effect on the average weekly weight gain of the rats, it caused a significant increase in rela tive liver and spleen weights. The mean platelet volume and osmotic fragility of red blood cells were reduced which indicates an effect on biological membrane struc ture and possibly on membrane functions. This study, as well as the previous study on MaxEPA_??_, appears to confirm some beneficial effects of fish oil consumption in the reduction of total serum cholesterol level in male and female rats. However, as a concomitant reduction in the serum HDL levels was seen as well, the benefit of this effect should be interpreted and extrapolated to hu mans with extreme caution. An important finding, not reported by others, was the adverse effect of fish oil on total seruu iron in female rats. In confirmation of re ports by others and by us, we also observed a significant reduction in serum vitamin E levels in male and female rats treated with the high doses offish oils concentrates. We conclude that rats, especially females, given sub chronic and high doses of FOC develop potentially harmful changes in several biochemical indices. These include increased red cell deformity, increased relative liver and spleen weights, and reduced MPV, absolute amount of serum HDL, serum iron and serum vitamin E concentrations. 
